Correction To: Intravenous Ferric Carboxymaltose in Patients With Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol
Diabetes Therapy - United States
doi 10.1007/s13300-018-0546-6
Full Text
Open PDFAbstract
Available in full text
Date
December 6, 2018
Authors
Publisher
Springer Science and Business Media LLC